ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

ÀÇ·áÁø »çÁø
ÀÌÀ±Á¤ ±³¼ö
Àü¹®¼¾ÅÍ ¼ÒÈ­±â¼¾ÅÍ
Áø·á°ú ¼ÒÈ­±â³»°ú HOME

Àü¹®Áø·áºÐ¾ß

±Þ¼º ¹× ¸¸¼º °£¿°, °£¾Ï, ¾ËÄڿüº °£Áúȯ, Áö¹æ°£(´ë»çÀÌ»ó Áö¹æ°£Áúȯ), °£°æº¯Áõ ¹× ÇÕº´Áõ °ü¸®, °£ÀÌ½Ä ÀüÈÄ °ü¸®, À§/´ëÀå ³»½Ã°æ

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2026-08-31 ~ 2026-09-05)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á

ÇзÂ

ÇзÂ

¼­¿ï´ëÇб³ Çлç Á¹¾÷

°æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø Á¹¾÷

°æ·Â

°æ·Â

°í·Á´ëÇб³¾È»êº´¿ø ³»°ú Àü°øÀÇ

ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ÀüÀÓÀÇ

¹Ì±¹ ´º¿å ¸¶¿îÆ®½Ã³ªÀ̺´¿ø °£ÀÌ½Ä ¹× °£Áúȯ ½ÉÈ­ ÀüÀÓÀÇ(Advanced Fellowship)

ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ¼ÒÈ­±â³»°ú Áø·áÁ¶±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѰ£ÇÐȸ ȸ¿ø

¹Ì±¹°£ÇÐȸ(AASLD) ȸ¿ø

¹Ì±¹À̽ÄÇÐȸ(AST) ȸ¿ø

º¹ºÎÃÊÀ½ÆÄ ¼¼ºÎÀü¹®ÀÇ

¼ÒÈ­±â³»½Ã°æ ¼¼ºÎÀü¹®ÀÇ

¹Ì±¹ Echosens»ç °£¼¶À¯È­°Ë»ç (FibroScan) ÀÎÁõ (Operator/Provider Certification)

³í¹®/Àú¼­

³í¹®/Àú¼­
³í¹®
1. 2025 Lee, Yunjeong, et al. ¡°Efficacy of Radiotherapy in combination with Immune checkpoint blockade for hepatocellular carcinoma and portal vein tumor thrombosis.¡± The Korean Journal of Medicine.
2. 2021 Lee, Yunjeong, et al. "Extraintestinal Manifestation of Yersinia pseudotuberculosis Bacteremia as Acute Hepatitis: Case Report and Review of the Literature." Pathogens.

Çмú¹ßÇ¥
1. 2024.06 À¯·´°£ÇÐȸ (EASL Congress 2024, ÀÌÅ»¸®¾Æ ¹Ð¶ó³ë): "External beam radiation therapy improves the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombosis."

2. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Nucleos(t)ide Analogues Help Preserve Liver Volume in Chronic Hepatitis B Patients with Low Viral Load."

3. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Predictors of Hepatitis Flare and Initiation of Antiviral Therapy in Nucleos(t)ide Naïve Chronic Hepatitis B in Grey Zone."

4. 2023.11 ¹Ì±¹°£ÇÐȸ (The Liver Meeting 2023, ¹Ì±¹ º¸½ºÅÏ): "Does Senescent Change in Spleen Affect Splenomegaly in Elderly Patients with Liver Cirrhosis."